MCF Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02K Buy
50
+1
+2% +$23 ﹤0.01% 1319
2026
Q1
$1.09K Buy
+49
New +$853 ﹤0.01% 1256
2019
Q3
Sell
-140
Closed -$3K 450
2019
Q2
$3K Hold
140
﹤0.01% 400
2019
Q1
$5K Hold
140
﹤0.01% 376
2018
Q4
$4K Hold
140
﹤0.01% 399
2018
Q3
$6K Hold
140
﹤0.01% 382
2018
Q2
$6K Hold
140
﹤0.01% 367
2018
Q1
$7K Sell
140
-33
-19% -$1.65K ﹤0.01% 355
2017
Q4
$9K Hold
173
﹤0.01% 340
2017
Q3
$9K Hold
173
﹤0.01% 351
2017
Q2
$7K Hold
173
﹤0.01% 381
2017
Q1
$7K Sell
173
-41
-19% -$1.23K ﹤0.01% 370
2016
Q4
$5K Hold
214
﹤0.01% 365
2016
Q3
$3K Sell
214
-66
-24% -$754 ﹤0.01% 394
2016
Q2
$2K Buy
280
+66
+31% +$588 ﹤0.01% 457
2016
Q1
$1K Hold
214
﹤0.01% 424
2015
Q4
$1K Sell
214
-200
-48% -$1.28K ﹤0.01% 441
2015
Q3
$3K Buy
+414
New +$4.33K ﹤0.01% 395

Other funds holding CC

MCF Advisors's CC Position: Q2 2026 in Review

MCF Advisors increased its Chemours (CC) stake by 2% in Q2 2026, buying an estimated $23 and bringing the position to 50 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

MCF Advisors first reported a position in CC in Q3 2015 and has held it in 18 quarters since. The position peaked at $9K in Q4 2017. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • MCF Advisors held 50 shares of Chemours worth $1.02K as of Q2 2026.
  • MCF Advisors bought 1 Chemours share in Q2 2026, an estimated $23.
  • Chemours made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1319 holding.
  • MCF Advisors first reported a position in Chemours in Q3 2015 and has held it in 18 quarters since.
  • MCF Advisors's Chemours position peaked at $9K in Q4 2017.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.